Year: 2025
Type: article
Abstract: Since obesity is a chronic, multifaceted, and heterogeneous disease influenced by genetic, biological, and environmental factors, it is imperative to approach obesity with an included and complete treatment strategy. Obesity is one of the resulting causes of morbidity and mortality worldwide, and its incidence is increasing globally. Despite significant advancements in the treatment of obesity-related conditions such as high blood pressure, type 2 diabetes, and high cholesterol, treating obesity itself remains a challenging undertaking. Many antiobesity medications (AOMs) don't work as prescribed, leading to insufficient weight loss and safety concerns. This review investigates the evolution of AOM, highlighting past successes and failings to shed light on contemporary problems. Recent advances, particularly in understanding the molecular dialogue between the gut and brain, offer prospective avenues for the next generation of AOMs. These might hold the key to safely and effectively accomplishing substantial, long-term weight loss
Institution: University of Kerbala
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4412962648